CSIMarket
 


Cure Pharmaceutical Holding Corp   (CURR)
Other Ticker:  
 

Cumulative Cure Pharmaceutical Holding 's Long Term Debt to Equity for Trailing Twelve Months Period

CURR's Long Term Debt to Equity for Trailing Twelve Months Period and Long Term Debt, Equity growth


Select the Comparisons : Select the Ratio:

CURR Long Term Debt to Equity for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2015)
II. Quarter
Y / Y Equity Growth - - - - -
Y / Y Long Term Debt Growth - - - - -
Long Term Debt to Equity for Trailing Twelve Months Period 0.63 0.63 0.35 0.01 -
Total Ranking # # # # #
Seq. Equity Growth - -76.13 % -24.91 % 85162.21 % -
Seq. Long Term Debt Growth - -0.69 % 4022.55 % - -


Long Term Debt to Equity for Trailing Twelve Months Period Comment
On the trailing twelve months basis In the III. Quarter Cure Pharmaceutical Holding did not have Long Term Debt .
Long Term Debt to Equity for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry Cure Pharmaceutical Holding Corp achieved lowest Long Term Debt to Equity for Trailing Twelve Months Period. While total ranking remained unchanged compare to previous quarter at no. .

What is Long Term Debt to Equity Ratio?
What is CURR selling?
Long Term Debt to Equity CURR in the most recent quarter
Long Term Debt to Equity for Trailing Twelve Months Period Company Ranking
Within: No.
Industry #
Sector #
S&P 500 # 0


Long Term Debt to Equity for Trailing Twelve Months Period Statistics
High Average Low
0 0 0
 




Companies with similar average Long Term Debt to Equity for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Major Pharmaceutical Preparations Industry Long Term Debt to Equity for Trailing Twelve Months Period
Sarepta Therapeutics Inc   1.70 
Molecular Templates Inc   1.65 
Jazz Pharmaceuticals Plc  1.65 
Xeris Biopharma Holdings Inc   1.63 
Teligent Inc   1.45 
Innoviva Inc   1.44 
Biovie Inc   1.40 
Assertio Holdings inc   1.38 
Zoetis Inc   1.37 
Evolus Inc   1.36 
Teva Pharmaceutical Industries Limited  1.31 
Axsome Therapeutics Inc   1.26 
Eli Lilly And Company  1.21 
Travere Therapeutics Inc   1.20 
Amicus Therapeutics inc   1.18 
Alnylam Pharmaceuticals Inc   1.17 
Mallinckrodt Plc  1.15 
Marinus Pharmaceuticals Inc   1.12 
Sophiris Bio Inc.  1.12 
Prestige Consumer Healthcare Inc   1.09 
Amag Pharmaceuticals inc   1.07 
Ionis Pharmaceuticals Inc.  1.04 
Bristol myers Squibb Company  1.03 
Puma Biotechnology Inc   1.03 
Catalent Inc   1.00 
Viatris Inc   0.97 
Ironwood Pharmaceuticals inc   0.94 
Evoke Pharma Inc   0.90 
G1 Therapeutics Inc   0.89 
Ani Pharmaceuticals inc  0.87 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

PRKA's Profile

Stock Price

PRKA's Financials

Business Description

Fundamentals

Charts & Quotes

PRKA's News

Suppliers

PRKA's Competitors

Customers & Markets

Economic Indicators

PRKA's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071